Applied DNA Sciences (APDN) Misses Q3 EPS by 5c, Revenues Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. GMAB
4. ACCV
5. FLG
6. META
7. FICO
8. SMMT
9. QQQ
10. SPCX

Go back to Applied DNA Sciences (APDN) Misses Q3 EPS by 5c, Revenues Miss

Applied DNA Reports Fiscal Third Quarter 2018 Financial Results

August 13, 2018 4:05 PM EDT

Company to Hold Conference Call and Webcast Today,
Monday, August 13, 2018 at 4:30 PM EST-

STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the "Company"), announced financial results for the fiscal 2018 third quarter ended June 30, 2018.

Commenting on Applied DNAs results for the fiscal third quarter, Dr. James A. Hayward, president and CEO, stated, Results for the quarter did not fulfill our expectations for recognized revenue due to the shipping of an initial cotton DNA order under extended payment terms.... More